Nevertheless, evidence suggests that sophocarpine can mitigate cancer-induced cachexia by concurrently reducing the levels of TNF-α and IL-6 in RAW264.7 cells and macrophages (Zhang et al., 2008), indicating the possible involvement of inflammatory cytokines in the antitumor effects exerted by sophocarpine. The gene discussed is TNF; the disease is Cachexia.